One life was saved for every 456 men invited for a prostate cancer screening, the study found. View on euronews ...
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...
MedPage Today on MSN
PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show
A sustained reduction in deaths from prostate cancer was observed with prostate-specific antigen (PSA) testing in long-term ...
EDITOR’S NOTE: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. When I learned that ...
MedPage Today on MSN
Mixed Results With Metformin for Men on ADT for Prostate Cancer
The favorable effects observed in the study "consolidate the finding that metformin not only improves anthropometric outcomes ...
Scott Tagawa, MD, highlights the PSMAddition trial's promising results, showcasing Lutetium-177 PSMA-617's significant ...
On-treatment PSA and disease burden should be considered together for prognostication. Achieving PSA ≤0.2 ng/mL within 6–12 weeks strongly predicts favorable long-term survival. Metastatic volume and ...
Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for Getty Prostate cancer is one of the most common types of cancer in males. It starts in the prostate, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback